Can someone help me out here and let me know how this helps out SYN? Are these not just the property of the university and the good doctor? Or can SYN now negotiate for all of these additional patents?
I've just posted this question within a different thread, but wanted to repost for visibility:
Does anyone here have any knowledge on those 4 additional patents Riley claimed to have filed with Trimesta? You know, the ones they filed after they saw enough significant data from the MRI's? Were they successfully filed? How long until we see paperwork there? What might they be covering? And I know Dr. V is looking to pair testosterone with Copaxone, any guidance on SYN securing this patent as well? I've been searching and can't find much, and this was ages ago that Riley made these comments. Would love guidance here.
Does anyone here have any knowledge on those 4 additional patents? Were they successfully filed? How long until we see paperwork there? I've been searching and can't find much, and this was ages ago that Riley made these comments. Would love guidance here.
Come on Riley and Rhonda...strike while the iron is hot!!!!
So NVGN can cross the blood-brain barrier, and the company looks to have a number of very significant shots on goal coming in the next few years. This seems like quite a significant play. I've got shares long from the low 7's and the mid 5's and will continue to add, and wanted to thank you for putting the stock on my radar.
Question is, what am I missing here? Market cap is, what, 50 mil? Do you think Kelly's stance on making game changing cancer drugs affordable to the masses something that the market hates? I'm all about it, as a disclaimer, and would be happy with a muted return if that meant that the treatment was available to multitudes more people, but the market would hate this approach.
Also know that everything is in the experimental phase here as well and we're a long way off from anything to get super excited about, but the pump seems primed here.
If SYN pops, I'm planning on moving profits into NVGN, as a disclaimer...I really like what I'm seeing here.
Your feedback is welcome
Completely agree with you and pacman above in that this wouldn't impact those w/o IBS...but, to the upwards of 40 million people who have IBS, just image how valuable a drug will be to them that will knock out IBS, plus lower weight and cholesterol with no side effects and one that needs to be administered daily. I'm confident people would pony up for such a drug.
Throw diabetes in on top of this...forget about it.
Really interesting to hear Pimentel talk about the bacteria over digesting food and, thus, dumping more than the normal/perceived calorie load onto your system, thus causing people to gain weight. How many people fit into this category? Those who eat well, work out and just can't seem to get anywhere? If our little drug helps even a small fraction of this crowd as well then this could be one of the drugs of the decade.
I'm way overweight SYN but will now continue buying.
UGT, still think your valuations are very rich, but given this development, my valuations have just moved closer to yours.
Anyone else think this is as significant as I do? Thought this would be all over the board today. Comments welcome!
that's to say...take a pill that will disrupt the methane..NOT disrupt the microbiome. Was typing while listening to the Q&A session. This is a huge confirmation of some rumors that were floating around this board a long time back. This changes everything if we get both weight loss and an immediate drop in cholesterol with no side effects...seriously, mega-block buster if that pans out $multi-billion easy
My shares are on lock
Sentiment: Strong Buy
Killing it with this presentation. Pimentel's comments on weight loss and cholesterol are huge!
Just take a breath test for methane, take a pill that won't disrupt the methane and problems are gone...but you've gotta stay on the drug as it's not an antibiotic.
Love this news!
Expedited phase 2 and 3 as just mentioned